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Methods and Results: Patients with ACS (N121) receiving IABP support were
enrolled. Survivors and non survivors were compared at 30-days.
Mortality rate was 47%. The survivors (N64) had a higher proportion of non-
cardiogenic shock (CS) (p0.001), more IABP usage as back-up for a revascularization
procedure (p0.002), and fewer history of resuscitation (p0.043) and mechanical
ventilator support (p0.001). Compared to survivors, the non survivors had signifi-
cantly higher leucocyte level (p0.033), higher creatinine level (p0.001), higher blood
sugar on admission (p0.001), higher serial CKMB level (p0.002) and higher uric acid
level (p0.001), but significantly lower left and right ventricular function (p0.014 and
p0.003, respectively). At 30 days, non-ST elevation (STE) ACS patients had higher
cumulative survival than STEMI patients (log rank, p 0.001) and non CS non
STE-ACS patients showed the highest cumulative survival (p 0.001).
By multivariable analysis, heart rate 100 x/minute prior to IABP insertion was the
strongest predictor of 30-days mortality (Hazard Ratio 5.66; 95% CI 1.47 - 21.70; p
0.011).
Conclusion: In ACS patients presenting with cardiogenic shock, resuscitated or need for
mechanical ventilation, the short term mortality remains high, despite the use of IABP.
IABP appears to be favourable in non cardiogenic shock ACS patients especially non
STE-ACS. A heart rate of  100 x/minute prior to IABP insertion was the strongest
predictor of 30-days mortality.
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Background: Recent studies in large worldwide populations demonstrate that the
metabolic syndrome (MS) increases the risk of acute myocardial infarction (AMI) without
gender, ethnic or regional variations. The risk of AMI associated with MS appears no
greater than the risk conferred by its individual components.
Objective: The goal of the study is to investigate the prevalence of metabolic syndrome
in young patients with acute myocardial infarction (AMI) treated with percutaneous
coronary intervention (PCI) and to compare the ATP III individual components of MS
in young versus old patients.
Method: A retrospective analysis of the University of Southern California interventional
cardiology database was performed to identify patients with AMI (STEMI and
NSTEMI, n779) treated with PCI between January 2008 and June 2011. Two groups
were generated according to the patient’s age: young (45 years of age, n81) and old
(45 years of age, n698). Patients with MS were identified by the presence of at least
3 of the ATP III criteria and components of the MS were separately compared by age.
Results: The MS was more prevalent in young patients with AMI (60.5% vs. 44.8%,
p0.02). Older patients were found to have higher rates of Hypertension (40.7% vs.
64.6%, p0.001). Triglyceride levels were higher in younger patients (212mg/dl vs.
153.4mg/dl, p-value0.014), while HDL levels (38.18mg/dl vs. 40.18mg/dl, p0.22)
and obesity rates (BMI 30kg/m2, 25.92% vs. 26.5%, p0.97) were similar between the
groups. Single vessel CAD was more common in younger with MS patients (44.6% vs.
71.7%, p0.001), as well as total occlusion of the infarct related artery (39.7% vs. 19.1%,
p0.0003).
Conclusions: The MS is highly prevalent in young patients with AMI. Younger patients
compared to older patients with AMI treated with PCI have higher triglyceride levels, less
hypertension, are more likely to have single vessel CAD and present with a totally
occluded vessel.
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Background: The main benefit of DES vs. BMS in PCI is reduced revascularization.
Recent data also suggest reduced major adverse cardiac events (MACE) with DES used
in the context of MI yet many patients (pts), especially the uninsured do not receive DES.
We evaluated BMS vs. DES in a public health system (PHS) population with uniform
access to healthcare and stratified by presentation acuity.
Methods: 2,000 pts undergoing PCI at a PHS hospital were analyzed as an open cohort.
Pts were included if complete data were available and uniform access to healthcare was
provided at the same PHS. Pts were analyzed by DES vs. BMS, stratified by stable vs.
unstable (ACS, MI, shock) clinical presentation and followed for MACE (death, MI,
urgent TVR).
Results: 1,702 pts (57.2 10.2 yrs, 31.8% female, 45.9% AA, 22.5% White) underwent
PCI for STEMI (19.2%), NSTEMI (28.0%), unstable angina (24.7%) or stable angina
(18.9%). The majority (1,402, 82.4%) received BMS. Clinical follow-up was obtained in
85.1% of pts (n1702, mean 2.5y  1.9 yrs). MACE at 3 years was highest in
unstable/BMS pts and lowest in stable/DES pts (Fig. 1). Notably the difference between
DES and BMS in the unstable cohort was driven by mortality reduction.
Conclusions: DES confers a MACE and likely mortality advantage over BMS,
especially in unstable pts. DES was utilized in the minority of pts in this cohort, likely
reflecting a significant selection bias. Additional multivariate analyses are currently
underway to evaluate the true magnitude and mechanisms of benefit.
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Background: Previous literature has demonstrated the safety of abbreviated GP IIbIIIa
infusion in elective PCI. There is no data to date on the safety of abbreviated infusion of
GPIIbIIIa inhibition in the setting of primary PCI for STEMI.
Methods and Results: A retrospective cohort of STEMI patients undergoing primary
PCI from June 2009 - June 2011 was analyzed. Detailed demographic, intervention and
complication data was collected. A logistic regression model was utilized to identify
univariate and multivariate predictors of a pre-specified primary combined endpoint of
death/vascular complication/transfusion/stent thrombosis. 66 patients with a mean age of
61  13 years (27% female, 26% diabetic) were identified. Six patients had cardiogenic
shock on admission (9%). Symptom onset to device time was 312318 min and lab to
device time was 1910 min. There were 6 patients (9%) with a pre lab cardiac arrest.
Mean LVEF was 5312 % and peak CK was 19912130U. Successful PCI (TIMI 3
flow and residual stenosis  20%) was achieved in 64 (97%). Thrombectomy was
performed in 45 (68%) patients. Stents were deployed in 65 (98%) with 1.60.5 stents
(mean length 3119) mm delivered to a mean of 1.10.4 lesions. Mean duration of
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eptifibatide was 3.83.3 hours. Femoral access was utilized in 60 patients (91%) with
closure devices in 39 (59%) and IABP used in 6 (9%). Three patients underwent index
admission CABG (2 elective, 1 urgent). There were 3 in-hospital deaths due to
cardiogenic shock (5%). There were no recurrent infarctions or stent thrombosis. There
was 1 AV fistula and 1 small retroperitoneal bleed not requiring surgery or transfusion.
Three patients received transfusion (2 post CABG, 1 GI bleed).
Univariate predictors of death/vascular complication/stent thrombosis/transfusion in-
clude: pre-lab arrest (p0.0006), IABP use (p0.014), transfer patient (p0.002) and
shock on admission (p0.03); the only independent predictor was pre-lab arrest (p0.03,
OR 11.1 (95% CI 1.2-129.6).
Conclusion: Abbreviated duration GPIIbIIIa may be a safe and novel alternate during
STEMI. Major bleeding post infarct PCI was low with no access site related transfusion
or surgery and no stent thrombosis.
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Background: Percutaneous coronary intervention (PCI) is superior to fibrinolytic
therapy (FT) in patients with ST elevation myocardial infarction (STEMI). However,
treatment delays in patients with STEMI presenting at rural hospitals that are transferred
for PCI may result in longer door to balloon time and lose the advantage of this approach
over FT.
Methods: We conducted a retrospective study of all patients presenting with STEMI
and undergoing PCI (primary, rescue and routine) at our center from January 2003
through May 2010. These patients were classified into two groups: Group 1 consisted of
patients presenting at rural hospitals that were transferred to our center for PCI and group
2 consisted of patients directly presenting to our center. The “total” door to balloon time
(TDBT) was calculated in minutes from the first documented time of initiation of
symptoms of the index event until the balloon inflation of the culprit artery. The primary
endpoint was major adverse cardiac events (MACE) which was a composite of one year
incidence of all cause mortality, recurrent acute coronary syndrome (RACS), and
cerebrovascular accident (CVA)/transient ischemic attack (TIA). Secondary endpoints
were individual components of MACE including all cause mortality, RACS, CVA/TIA
and in-hospital major bleeding. We conducted multivariate regression analysis to evaluate
the role of major demographic and clinical characteristics in predicting MACE.
Results: A total of 410 patients (278 in group 1 and 132 in group 2) qualified for the
study. There were no significant differences in the major demographic and clinical
characteristics between the two groups. TDBT was 177 75 minutes in group1 and 97
64 minutes in group 2 (p 0.01). Primary endpoint occurred in 20 % of patients in group
1 and 12 % of patients in group 2 (p 0.048). However, none of the secondary endpoints
were significantly different between the two groups. By multivariate regression analysis,
only rural transfer status and TDBT predicted MACE.
Conclusion: Rural Interhospital transfer of patients presenting with STEMI is associ-
ated with longer TDBT and higher incidence of MACE. Further research is needed to
realize the full benefit of PCI in these patients.
CRT-16
Correlation Between Myocardial Perfusion Grade And St Segment Among Patients
With Normal Coronary Epicardial Flow After Primary Angioplasty In Acute
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Background: After Primary Angioplasty in acute myocardial infarction (PAAMI), the
TIMI of myocardial perfusion grade (TMPG) “myocardial blush”, is a useful but
subjective method of microcirculation analysis, with prognostic implications. On the other
hand, the addition of complete ST segment resolution (CSTR)70% is a hard and
more objective marker, providing information about tissue level perfusion. We analyzed if
exist correlation between TMPG and CSTR in patients with normal epicardial flow
TIMI 3.
Material and Methods: From January 2007 to September 2012, we analyzed
retrospectively the ECG (at admission and after 30 minutes from angioplasty) and the
TMPG from 406 patients (4 centers from Argentina), with PAAMI12hs, all these
patients with normal epicardial flow TIMI 3.The admission Killip and Kimbal was A
86%, B11% and D3%. We evaluated the microcirculation grades like TMPG 3
normal entry and exit of dye from the microvasculature, TMPG 2 delayed entry and exit
of dye from the microvasculature, TMPG 1 Dye slowly enters but fails to exit the
microvasculature and TMPG 0 failure of dye to enter the microvasculature. We defined:
opened microcirculation if TMPG was 2/3 and closed if TMPG was 0/1 at the final result
of PAAMI. We considered CSTR, like70% reduction of ecg after angioplasty, from
the initial value at admission. We had 84 patients with mechanical Thrombus Aspiration,
40 cases in TMPG0/1 group and 44 in TMPG2/3.
Results: 280/406 patients (68,9%) had CSTR at 30 minutes. Complete CSTR was
more significative in patients with opened TMPG 2/3 (240/302, 79,47%) than patients
with closed TMPG 0/1 (40/104, 38,4%), in spite of normal coronary epicardial flow;
P0.0004.
Conclusion: Exist direct correlation between CSTR and opened TMPG 2/3. Both
methods were useful in the analysis of microcirculation.
Timi Flow and ST segment after PAAMI, using Fisher’s test. P0.0004
n406 (TMPG2/3) 302 (TMPG0/1) 104
(CSTR) 280 240 (79,47%) 40 (38,4%)
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Background: After Primary Angioplasty in acute myocardial infarction (PAAMI), the
TIMI of myocardial perfusion grade (TMPG) “myocardial blush”, is a useful method of
microcirculation analysis, with prognostic implications. On the other hand, the presence
of angiographic thrombus (AT) generates distal embolism, affecting the microcirculation.
We analyzed if AT can predict bad myocardial blush after the angioplasty.
Material and Methods: From January 2007 to September 2012 we studied retrospec-
tively coronary angiograms and the TMPG of 406 patients from 4 centers of Argentina,
with PAAMI12 hours, all these patients with TIMI 3 after angioplasty. The average
age was 5814 years old. The admission Killip and Kimbal was A 86%, B11% and
D3%. We evaluated the microcirculation grades like TMPG 3 normal entry and exit of
dye from the microvasculature, TMPG 2 delayed entry and exit of dye from the
microvasculature, TMPG 1 Dye slowly enters but fails to exit the microvasculature and
TMPG 0 failure of dye to enter the microvasculature. We considered (opened circulation)
if TMPG was 2/3 and closed if TMPG was 0/1, at the final result of PAAMI. We
defined AT like intraluminal globular filling defect in multiple angiographic views. We
had 84 patients with mechanical thrombus aspiration, 40 cases in TMPG0/1 group and
44 in TMPG2/3.
Results: The incidence of AT before PAAMI was 360/406 patients (88,66%). 98/104
patients had AT before Angioplasty  TMPG 0/1 after PAAMI (94,23%) Vs 262/302
patients with AT  TMPG 2/3, (86,75%); P0,62.
Conclusions: The presence of angiographic thrombus didn=t predict bad TIMI Flow,
obtaining a trivial trend toward more incidence of closed microcirculation.
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